Caribou Biosciences CRBU
NASDAQ CRBU
$0.56 +0.02 (+3.70%)
At close: Oct 22, 2026 · 4:00 PM EDT

Caribou Biosciences (CRBU) Preferred Stock Liabilities (2020)

Updated

Caribou Biosciences (CRBU) reported Preferred Stock Liabilities of $41.32 million for Q4 2020.

Analysis

Caribou Biosciences (CRBU) Preferred Stock Liabilities (2020) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Stock Liabilities (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn -
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn -
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn -
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn -
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn -
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn -
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn -
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn -
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn -
10 Caribou Biosciences 59.36 Mn -457.18 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2020 41.32 Mn
API Access

Caribou Biosciences Preferred Stock Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=preferred-stock-liabilities&ticker=CRBU&period=max&api_key=YOUR_API_KEY